| | |||||
| Ebola | |||||
| NEWS | |||||
| Regeneron's Ebola drug heading for October verdict from FDA The FDA has kicked off a six-month priority review of REGN-EB3, Regeneron's three-drug therapy for Ebola virus infection, setting up a decision by 25 ...
| |||||
| Gilead drug shows positive signs in early coronavirus testing The drug was originally developed for Ebola, but has never been approved. But the study did not have a control arm, so the results cannot be ...
| |||||
| COVID-19 pandemic: How nature steps in to refill 'empty forests' when animals disappear Our work involved identifying Ebola virus-free, but "at risk" countries to establish a potential means of achieving adequate levels of pandemic ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
| Send Feedback |
Tidak ada komentar:
Posting Komentar